NDR1 Antibodies

Santa Cruz Biotechnology provides a broad selection of NDR1 monoclonal antibodies for research focused on understanding NDR1's role in cellular processes. NDR1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NDR1, or Nuclear Dbf2-related protein 1, is a serine/threonine kinase that plays a critical role in cell cycle regulation and cellular response to stress. NDR1 participates in various signaling pathways that govern cell proliferation, differentiation, and survival, making it an important target for cancer research and therapeutic development. Research focused on NDR1 can provide insights into tumorigenesis and potential treatment strategies. NDR1 monoclonal antibodies enable precise detection and analysis of NDR1 expression patterns across different cell types and tissues. Studying NDR1's interactions with other proteins helps reveal its regulatory mechanisms and cellular functions. Understanding NDR1's role in cell cycle control contributes to knowledge about cancer development and progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular pathways and potential therapeutic targets.